文献速递肝病

慢加急性肝衰竭移植前临床病程对移植后生存的影响

Effect of the clinical course of acute-on-chronic liver failure prior to liver transplantation on post-transplant survival.
PubMed 文献 · J Hepatol · 2019-10-25

研究基于美国器官共享网络数据库,纳入登记后28天内接受肝移植的慢加急性肝衰竭(ACLF)患者,按EASL-CLIF标准分级。结果显示,登记时为ACLF-3但移植时改善至ACLF 0-2者1年生存率高于移植时仍为ACLF-3者(88.2% vs 82.0%,p<0.001);登记时为ACLF 0-2但移植时进展至ACLF-3者生存率低于维持ACLF 0-2者(83.8% vs 90.2%,p<0.001)。

要点

  • 移植前ACLF-3改善至ACLF 0-2与移植后1年死亡率降低相关(HR 0.65,95%CI 0.53-0.78)。
  • 循环衰竭、脑衰竭改善或脱离机械通气与移植后死亡率降低相关。
  • 60岁以上患者中,ACLF-3改善至ACLF 0-2者1年生存率显著更高。

核心结论

  • 登记时为ACLF-3、移植时改善至ACLF 0-2的患者,移植后1年生存率高于移植时仍为ACLF-3者。
  • 登记时为ACLF 0-2、移植时进展至ACLF-3的患者,移植后1年生存率低于移植时维持ACLF 0-2者。
  • ACLF-3改善至ACLF 0-2与移植后1年死亡率降低独立相关(HR 0.65,95%CI 0.53-0.78)。

研究设计与样本

  • 基于美国器官共享网络(UNOS)数据库的回顾性队列研究,纳入登记后28天内接受肝移植的患者,按EASL-CLIF标准定义ACLF分级。

主要发现

  • 登记时为ACLF-3并在28天内移植者共3,636例,其中892例(24.5%)移植时改善至ACLF 0-2,2,744例(75.5%)移植时仍为ACLF-3。
  • 移植时ACLF-3者1年生存率为82.0%,改善至ACLF 0-2者为88.2%(p<0.001)。
  • 登记时为ACLF 0-2但移植时进展至ACLF-3者(n=2,265)1年生存率为83.8%,维持ACLF 0-2者(n=17,631)为90.2%(p<0.001)。
  • 循环衰竭改善、脑衰竭改善及脱离机械通气均与移植后死亡率降低相关。
  • 60岁以上患者中,从ACLF-3改善至ACLF 0-2者1年生存率显著高于未改善者。

关键数值与推荐

  • ACLF分级采用EASL-CLIF定义。
  • 从ACLF-3恢复至ACLF 0-2与1年移植后死亡率降低相关:HR 0.65(95%CI 0.53-0.78)。

临床怎么用

  • 对于等待肝移植的ACLF-3患者,移植前临床改善(尤其是循环衰竭、脑衰竭改善或脱离机械通气)可显著改善移植后生存,支持在移植前优化病情。
  • 60岁以上ACLF-3患者若移植前改善至ACLF 0-2,仍可获得移植后生存获益。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Patients with acute-on-chronic liver failure (ACLF) can be listed for liver transplantation (LT) because LT is the only curative treatment option. We evaluated whether the clinical course of ACLF, particularly ACLF-3, between the time of listing and LT affects 1-year post-transplant survival. METHODS: We identified patients from the United Network for Organ Sharing database who were transplanted within 28 days of listing and categorized them by ACLF grade at waitlist registration and LT, according to the EASL-CLIF definition. RESULTS: A total of 3,636 patients listed with ACLF-3 underwent LT within 28 days. Among those transplanted, 892 (24.5%) recovered to no ACLF or ACLF grade 1 or 2 (ACLF 0-2) and 2,744 (75.5%) had ACLF-3 at transplantation. One-year survival was 82.0% among those transplanted with ACLF-3 vs. 88.2% among those improving to ACLF 0-2 (p <0.001). Conversely, the survival of patients listed with ACLF 0-2 who progressed to ACLF-3 at LT (n = 2,265) was significantly lower than that of recipients who remained at ACLF 0-2 (n = 17,631) at the time of LT (83.8% vs. 90.2%, p <0.001). Cox modeling demonstrated that recovery from ACLF-3 to ACLF 0-2 at LT was associated with reduced 1-year mortality after transplantation (hazard ratio0.65; 95% CI 0.53-0.78). Improvement in circulatory failure, brain failure, and removal from mechanical ventilation were also associated with reduced post-LT mortality. Among patients >60 years of age, 1-year survival was significantly higher among those who improved from ACLF-3 to ACLF 0-2 than among those who did not. CONCLUSIONS: Improvement from ACLF-3 at listing to ACLF 0-2 at transplantation enhances post-LT survival, particularly in those who recovered from circulatory or brain failure, or were removed from the mechanical ventilator. The beneficial effect of improved ACLF on post-LT survival was also observed among patients >60 years of age. LAY SUMMARY: Liver transplantation (LT) for patients with acute-on-chronic liver failure grade 3 (ACLF-3) significantly improves survival, but 1-year survival probability after LT remains lower than the expected outcomes for transplant centers. Our study reveals that among patients transplanted within 28 days of waitlist registration, improvement of ACLF-3 at listing to a lower grade of ACLF at transplantation significantly enhances post-transplant survival, even among patients aged 60 years or older. Subgroup analysis further demonstrates that improvement in circulatory failure, brain failure, or removal from mechanical ventilation have the strongest impact on post-transplant survival.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Sundaram V, Kogachi S, Wong RJ, et al. Effect of the clinical course of acute-on-chronic liver failure prior to liver transplantation on post-transplant survival. J Hepatol. 2019. PMID: 31669304. doi:10.1016/j.jhep.2019.10.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。